THERALINK TECHNOLOGIES, INC.
THER | $0.001 62.5% 120K
|
n/a
(0.0% 1d) (12.5% 1m) (-64.0% 1y) (0.0% 2d) (0.0% 3d) (-10.0% 7d) (35.94% volume)
Earnings Calendar:
Market Cap: $ 6,151,500
Sec Filling | Patents | 2 employees
theralink technologies, inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapy products. the company has proprietary rights to immunotherapy platform focusing on prostate and breast cancers. the company's lead product is proscavax, which is in phase 2 clinical trials for the treatment of prostate cancer. it is also developing targeted therapies. theralink technologies, inc. has a partnership with perthera, inc. to facilitate and enhance access to theralink's 32 phosphoprotein panel, the theralink assay, for breast cancer patients. the company was formerly known as oncbiomune pharmaceuticals, inc. and changed its name to theralink technologies, inc. in september 2020. theralink technologies, inc. is based in baton rouge, louisiana.
add to watch list Paper trade email alert is off
Press-releases
Laser Capture Microdissection Market Worth $306 million | MarketsandMarkets™
Published: 2024-03-14 (Crawled : 14:30) - prnewswire.com
THER | $0.001 62.5% 120K
|
n/a
|
| O: 12.5%
H: 0.0%
C: 0.0%
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -0.39%
H: 0.7%
C: -1.03%
DHR | $235.51 -0.36% 0.0% 2.3M
|
Health Technology
|
| O: -0.58%
H: 0.69%
C: -0.26%
BIO | $279.73 -0.46% 0.0% 290K
|
Health Technology
|
| O: -0.58%
H: 0.36%
C: -0.62%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: 0.0%
million laser market
Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates
Published: 2023-12-18 (Crawled : 14:00) - globenewswire.com
THER | $0.001 62.5% 120K
|
n/a
|
| O: 0.0%
H: 7.14%
C: -14.29%
breast cancer theralink response therapy study
Theralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4
Published: 2023-11-13 (Crawled : 19:00) - globenewswire.com
BACK | $3.12 0.65% 0.64% 60K
|
Health Care and Social Assistan...
|
| O: 1.21%
H: 7.41%
C: 0.0%
THER | $0.001 62.5% 120K
|
n/a
|
| O: 0.0%
H: 7.69%
C: 7.69%
theralink response
Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute’s Molecular Tumor Board
Published: 2023-11-03 (Crawled : 13:00) - globenewswire.com
BACK | $3.12 0.65% 0.64% 60K
|
Health Care and Social Assistan...
|
| O: -0.3%
H: 0.0%
C: -9.22%
THER | $0.001 62.5% 120K
|
n/a
|
| O: 20.0%
H: 0.0%
C: 0.0%
theralink cancer tumor results molecular
Theralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023
Published: 2023-10-04 (Crawled : 13:00) - globenewswire.com
BACK | $3.12 0.65% 0.64% 60K
|
Health Care and Social Assistan...
|
| O: 3.78%
H: 2.51%
C: -1.04%
THER | $0.001 62.5% 120K
|
n/a
|
| O: 22.22%
H: 54.55%
C: -9.09%
expected theralink
IMAC Holdings Announces $4.3 Million Private Placement of Convertible Preferred Stock and Warrants Priced at the Market
Published: 2023-07-26 (Crawled : 13:00) - globenewswire.com
BACK | $3.12 0.65% 0.64% 60K
|
Health Care and Social Assistan...
|
| O: 1.65%
H: 0.0%
C: -2.07%
THER | $0.001 62.5% 120K
|
n/a
|
| O: -8.0%
H: 0.0%
C: 0.0%
market
Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer
Published: 2023-06-27 (Crawled : 13:00) - globenewswire.com
BACK | $3.12 0.65% 0.64% 60K
|
Health Care and Social Assistan...
|
| O: 3.51%
H: 0.16%
C: -3.23%
THER | $0.001 62.5% 120K
|
n/a
|
| O: 8.0%
H: 0.0%
C: -14.81%
theralink
Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company
Published: 2023-05-23 (Crawled : 13:20) - globenewswire.com
BACK | $3.12 0.65% 0.64% 60K
|
Health Care and Social Assistan...
|
| O: 9.31%
H: 32.06%
C: 3.23%
THER | $0.001 62.5% 120K
|
n/a
|
| O: 94.44%
H: 25.71%
C: -40.0%
theralink nasdaq acquired agreement
Theralink® Technologies Appoints Seasoned Commercial Leader, Faith Zaslavsky, as President & Chief Operating Officer for its Precision Oncology Company
Published: 2022-12-06 (Crawled : 14:00) - biospace.com/
THER | $0.001 62.5% 120K
|
n/a
|
| O: 0.0%
H: 0.0%
C: -2.86%
theralink commercial
Theralink® Technologies Accepted to Present Two Posters at the Upcoming San Antonio Breast Cancer Symposium
Published: 2022-12-01 (Crawled : 14:00) - biospace.com/
THER | $0.001 62.5% 120K
|
n/a
|
| O: 5.26%
H: 0.0%
C: -12.5%
theralink breast symposium cancer
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
KUKE | $2.88 2.49% 7.64% 360K
|
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
RNR 4 | $224.74 0.85% 3.52% 310K
|
Finance
BSBR | $5.25 2.54% 0.38% 430K
|
Finance
DV | News | $29.43 -2.36% 0.24% 1.9M
|
Information
JOE 4 | $54.88 1.22% 0.22% 210K
|
Finance
MUSA 4 | $417.23 1.06% 0.01% 170K
|
Retail Trade
DNB 4 | $9.17 0.22% 0.0% 1.9M
|
Technology Services
JBI 4 | $15.14 1.34% 0.0% 2.9M
|
SBS | $15.49 -1.59% -0.84% 4.6M
|
Utilities
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10